NCT06952127Completed
Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).
Pilot Study Evaluating the Feasibility and Appropriateness of a Telerehabilitation Exercise Program in People With Post-COVID-19 Sequelae: a Single-center Randomized Trial.
Source: ClinicalTrials.gov · Last updated 30 Apr 2025
Brief summary (registry, in English)
The goal of this study pilot randomized controlled study is to evaluate the feasibility of the study procedures and to compare the preliminary efficacy of a rehabilitation program given in a "remote" (telerehabilitation) or "face-to-face" model for adult patients who had confirmed SARS-CoV-2 infection and still have symptoms after eight weeks of infection. The main question it aims to answer is: * Are the study procedures feasible? * Will the two groups have similar results for the preliminary efficacy outcomes? Researchers will compare group telerehabilitation to a face-to-face group to see if it's comparable. Participants will: * Take part in a 60-minute training session, 3 times a week in person or remotely * Visit the clinic before starting the training program and after 8 weeks of training * Keep a diary of their symptoms, if any
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 22 (actual)
- First submitted
- 24 Apr 2025
- Start date
- 7 Apr 2023
- Primary completion date
- 29 Mar 2024
- Lead sponsor
- Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06952127
What you commit to
- Study type: Interventional
- Participants enrolled: 22
- From 7 Apr 2023 to the primary completion date, 29 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- evidence of medical instability (i.e., moderate or severe cardiac disease, ischemic or severe hemorrhagic stroke, or neurodegenerative disease, unstable fracture)
- history of severe cognitive or mental impairment
Other
- requiring in-hospital rehabilitation at discharge
- already enrolled in another rehabilitation program
Who the study is looking for
- adult patients (≥18 years)
- confirmed SARS-CoV-2 infection defined by positive polymerase chain reaction (PCR) testing and/or antigen test results
- referred to the pneumology clinic for a modified British Medical Research Council (mMRC) dyspnea score of 2-3 after a minimum of eight weeks of infection
- VO₂max of less than 80% of the predicted value
- receiving a medical prescription for rehabilitation following initial assessment by a pulmonologist
- being able to walk independently
- providing informed consent
- having a good internet connection (i.e., a minimum download speed of 4 Mbps and an upload speed of 4 Mbps)
- being in possession of a computer or tablet equipped with a camera enabling videoconferencing.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre hospitalier affilié universitaire régional Coordinator of this site? Confirm its status | Trois-Rivières | Canada | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.